Lung cancer
Conditions
Interventions
pCR group:The percentages of viable tumour cells, necrosis and stroma were respectively determined. The circumstance in which no viable tumour was observed was defined as a pathologic complete respons
Non-pCR group:The percentages of viable tumour cells, necrosis and stroma were respectively determined. The circumstance in which viable tumour was observed was defined as a non-pathologic complete re
Sponsors
Guangdong Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Aged over 18 years old; (2) Patients receiving radical lung cancer surgical resection after neoadjuvant immunotherapy combined with chemotherapy; (3) Pathologically confirmed stage IB-IIIB NSCLC patients; (4) Qualified 1 month before the first course of immunotherapy Chest CT data before surgery and surgery; (5) Follow-up time is no less than 6 months; (6) Complete clinical data
Exclusion criteria
Exclusion criteria: (1) There are no evaluable lung lesions, or the boundaries of the lesions are difficult to outline; (2) CT data have artifacts or the scan thickness is greater than 5 mm; (3) Clinical data or follow-up information are incomplete; (4) During immunotherapy Receive radiotherapy for the main target lesions; (5) Have a past or current history of other malignant tumors other than non-small cell lung cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major pathological response;pathological complete response; | — |
Secondary
| Measure | Time frame |
|---|---|
| disease free survival ;overall survival; | — |
Countries
China
Contacts
Public ContactHaiyu Zhou
Guangdong Provincial People's Hospital
Outcome results
None listed